Skip to main content

Identification of leptospiral 3-hydroxyacyl-CoA dehydrogenase released in the urine of infected hamsters



Leptospirosis is a global zoonosis caused by pathogenic Leptospira. The non-specific clinical signs and symptoms of leptospirosis lead to its misdiagnosis. To date, there is still no reliable rapid test kit that can accurately diagnose leptospirosis at bedside or in field. In this research, with the ultimate goal of formulating a rapid and accurate diagnostic tool for leptospirosis, we aimed to identify leptospiral proteins excreted in urine of infected hamsters, which are thought to mimic Weil’s disease.


Hamsters were subcutaneously infected with leptospires, and the general attributes of urine as well as the proteins excreted in it were examined. Some leptospiral proteins were found to be excreted in the urine from the early phase of infection. The most important finding of this study was the detection of the lipid-metabolizing enzyme, 3-hydroxyacyl-CoA dehydrogenase (HADH), before the onset of illness, when leptospires were not yet detected in the urine of infected hamsters.


This is the first report on the detection of leptospiral HADH in the host urine, which may be a possible candidate leptospiral antigen that can be used in the early diagnosis of human and animal leptospirosis.


Leptospirosis is a global zoonosis caused by the pathogenic Leptospira spp. Outbreaks of leptospirosis usually occur after heavy rains followed by floods in tropical and subtropical developing countries, and recreational activities in developed countries [1, 2]. The genus Leptospira is comprised of 21 species and more than 300 serovars. Animals may become maintenance hosts of some serovars or incidental hosts of others [3]. Infection of accidental hosts may cause severe or fatal disease. Wild rats, dogs, buffaloes, horses, and pigs are known to contract the disease and the surviving animals maintain the organisms in their kidneys. Infected animal urine contains leptospires, which may contaminate the environment once excreted, becoming a new source of infection for humans and susceptible animals. Infection of humans or animals occurs when leptospires penetrate both normal and injured skin and mucosal surfaces after direct contact with the urine of infected animals or indirectly from contaminated environments [1, 4].

Signs and symptoms of human leptospirosis are usually mild, however, 5% of cases develop the severe form presenting jaundice, renal failure, and pulmonary hemorrhage [1, 2, 46]. This zoonotic infection is treatable but its early phase has clinical presentations similar to many other diseases thereby complicating its clinical diagnosis. Early diagnosis of leptospirosis is essential to prevent progression to the severe stage because antibiotic treatment is effective when it is initiated early in the course of the disease.

The gold standards for diagnosis of leptospirosis are isolation of Leptospira by culture from blood, urine or tissues of infected hosts and the microscopic agglutination test (MAT) to detect antibody. However, results of these diagnostic methods can only be evaluated more than 10 days after the onset of illness. Furthermore, technical expertise is needed in order to perform the culture and MAT. In attempts to replace these two methods, other diagnostic methods were developed such as enzyme-linked immunosorbent assay (ELISA) [7], polymerase chain reaction (PCR) [811], and so on [1216]. However, these are not simple or rapid tests that can be used at bedside [1, 2, 4, 17] and sophisticated equipment is needed in order to perform PCR. In addition, with the exception of PCR, the sensitivities of the other assays are not satisfactory, especially during the acute phase of infection [18]. At present there is a lack of available kits that are able to detect leptospiral antigens in patient samples such as urine. Furthermore, there is also a need for simple and rapid leptospirosis diagnostic kits that are cheap, highly sensitive, highly specific, and can easily be used at bedside or in the field.

Urine is expected to be the best sample for diagnosis, because the urine of leptospirosis patients contains leptospiral antigens and can be collected easily [1926]. Urine of patients has often been used for culture of Leptospira, however, more information on proteins can be obtained from urine [27].

The golden Syrian hamster is susceptible to Leptospira infection, and acute leptospirosis in the hamster model reproduces the severe form of human leptospirosis, and is therefore useful in evaluating diagnostic methods [28]. In this study, we analyzed the characteristics and protein components of Leptospira-infected hamster urine in order to identify proteins that may be possibly used in developing rapid and accurate leptospiral antigen diagnostic kits. We identified a leptospiral protein, 3-hydroxyacyl-CoA dehydrogenase (HADH), which was found to be excreted in the urine of hamsters during the early phase of infection.


Changes in urine characteristics of hamsters during Leptospira infection

Hamsters were subcutaneously infected with 103 leptospires (strain K64), and their urine was collected daily in metabolic chambers for 6 h. All infected hamsters became markedly sick after the seventh day showing decreased mobility and body weight, ruffled fur, and decreased food and water intake, and became moribund from the eighth day post infection (Figure 1A). We confirmed that the cause of death was leptospirosis because leptospires were isolated from the blood, urine, and organs (lungs, livers, kidneys, spleens, and brains) of moribund hamsters. Normal hamster urine was alkaline (Figure 1B) and milky (Figure 1C). However, it became acidic (Figure 1B) and clear (Figure 1C) after the seventh day of infection. Urine culture was negative for leptospires until the sixth day, but became positive from the seventh day post infection (Figure 1A). Using urinalysis strips, we also found that the levels of glucose, specific gravity, blood, protein and bilirubin increased at the same time, whereas the levels of urobilinogen, nitrite, leukocyte and ketone did not change. Urinary protein level was 30 mg/dl before infection, and increased to 300 mg/dl on the seventh day post infection.

Figure 1

Survival of infected hamsters and sequential change of general urinary conditions during Leptospira infection. (A) Survival rate of infected hamsters and Leptospira-positivity ratio of the urine culture were checked every day. Hamsters were infected with 103 leptospires and urine was collected every day from pre-infection to just before death. Chemical analysis of hamster urine was done using urinalysis paper and absorbance was also measured at 600 nm. Infected hamsters became moribund from the eighth day post infection. Leptospires were recovered from the urine from the seventh day after infection. Three independent experiments were done (n = 10) and the sum of the survival rate of the 10 hamsters are shown. (B and C) Urinary pH (B) and absorbance (C) changed after the seventh day. Hamster infection experiments were repeated three times. The sum of the turbidity and pH values were taken and the average (±SD) are shown (n = 10). *: p < 0.05, **: p < 0.01.

Changes in hamster urinary proteins during leptospiral infection

The hamster urine was collected daily from pre-infection to just before death and the protein compositions were compared using SDS-PAGE. Until the sixth day post infection, urinary protein compositions were almost the same as that of pre-infection. Significant change was observed after 7 days of infection, particularly an increase in the density of approximately 66 kDa protein which is thought to be albumin (Figure 2A).

Figure 2

SDS-PAGE and immunoblotting of hamster urine protein during Leptospira infection. (A) Compositions of hamster urinary proteins were compared according to infection periods. Hamster urine was collected and prepared for SDS-PAGE. The urine of three hamsters was mixed for each infection period. The protein content of each sample was 5 μg. After separation with SDS-PAGE, the gel was stained by silver staining. (B) The anti-L. interrogans pAb recognized leptospiral proteins in infected-hamster urine by immunoblotting. These experiments were repeated three times, and the representative data are shown in this figure.

For detecting leptospiral proteins in hamster urine, we performed immunoblotting with rabbit polyclonal antibody against L. interrogans serovar Manilae. Three bands with sizes of 65, 52, and 30 kDa were detected in the post-infection urine (Figure 2B). These bands were already detected during the early phase of post-infection. During this phase, the hamster appeared healthy and no viable leptospires were recovered from the urine. 26 kDa protein was detected in urine before and during infection so this protein was not a result of infection.

Comparative analysis of urinary protein composition before and after Leptospira infection by using two dimensional electrophoresis (2-DE) and immunoblotting

As shown in the results of SDS-PAGE (Figure 2A), the composition of urinary proteins was found to have changed drastically after the seventh day of infection. To compare these components in detail, the urinary proteins of pre-infection and seventh day of infection were analyzed by 2-DE (Figure 3). The 2-DE pattern of urinary proteins changed after Leptospira infection. It was found that the level of approximately 66 kDa protein in the urine significantly increased on the seventh day (Figure 3A and B). By immunoblotting using anti-L. interrogans pAb, the 60 kDa spots were detected (Figure 3D, arrow). However, spots with other sizes were not detected in hamster urine (Figure 3D). 2-DE analysis were also done for urine samples at 3–4 days infection however the protein pattern was found to be the same as pre-infection urine samples and further analysis by immunoblot was also unable to detect any protein spots (data not shown).

Figure 3

2-DE analysis of normal and infected hamsters urine. Urinary protein patterns of hamsters were compared by 2-DE analysis; (A, C) before infection; (B, D) 7–8 days post-infection. The urine of three hamsters was mixed for each infection period. The total protein content of each sample was 20 μg. Each pattern of urinary protein was separated by pI (4–7), 12.5% acrylamide gel, and subsequently silver staining (A, B), or immunoblotting with anti-L. interrogans pAb was done (C, D). Arrows (D) show spots of 60 kDa that reacted with the polyclonal antibody at 7–8 days post-infection. Each experiment was repeated three times, and the representative data are shown in this figure.

Proteins with increased levels after Leptospira infection

A total of 29 protein spots that had increased density after infection (Figure 3B) were selected and analyzed by LC/MS/MS analysis. Database analysis showed that these urinary proteins were albumin, alpha-1-antitrypsin, alpha-1-inhibitor III, angiotensinogen, apolipoprotein A-I, ceruloplasmin, haptoglobin, pancreatic trypsin 1, pregnancy protein 60 kDa, protease serine 1, transferrin, transthyretin, AMBP protein, vitamin D-binding protein and Cu/Zn superoxide dismutase (Table 1). Most of these proteins were serum proteins, which are usually detected in the urine of patients with renal failure. It is noteworthy that some of the leptospiral proteins were also identified as ABC transporter, 3-hydroxyacyl-CoA dehydrogenase (HADH), chloride channel, and conserved hypothetical proteins in the urine (Table 2).

Table 1 List of hamster proteins excreted in urine that had increased levels of expression during infection
Table 2 List of leptospiral proteins excreted in hamster urine during Leptospira infection

Identification of HADH in hamster urine

As mentioned in the previous section, candidate leptospiral proteins in urine were selected based on the results of LC/MS/MS analysis. In order to identify leptospiral proteins that are excreted in hamster urine during infection, recombinant proteins for each selected protein were made. The proteins were screened by immunoblotting with anti-L. interrogans pAb. Among them, only HADH reacted to the antibody. The amino acid sequence of HADH are shown in the Additional file 1: Table S1 and had a coverage of 27%. The rHADH was purified with TALON® Metal Affinity Resin (Clontech) and its expression was confirmed with coomassie brilliant blue (CBB) staining (Figure 4A) and immunoblotting by anti-His (C-term) antibody (Figure 4B). The anti-L. interrogans pAb also recognized the rHADH (Figure 4C).

Figure 4

SDS-PAGE and immunoblotting of recombinant leptospiral HADH. (A) The rHADH with His-tag was produced by E. coli and purified by cobalt resin. In total, 1 μg of the protein was run by SDS-PAGE and CBB staining. (B) Anti-His-tag antibody and (C) anti-L. interrogans pAb detected the protein. Sharp signs indicate recombinant protein bands of 52 kDa. These experiments were repeated three times, and the representative data are shown in this figure.

Detection of HADH in infected hamster urine with antiserum

We produced anti-rHADH antiserum in rabbits, and examined its reactivity to rHADH by immunoblotting. The rabbit antiserum recognized the recombinant protein (data not shown). We then performed immunoblotting of urine samples as in Figure 2B and the antiserum reacted with the post-infection samples (Figure 5A). The reacted protein increased after the seventh day of infection (Figure 5B). The protein was found to be excreted in the urine before leptospires were shed (Figure 1A).

Figure 5

Immunoblotting of infected hamster urine by anti-HADH antisera. (A) Rabbit anti-rHADH serum was able to detect the 52 kDa protein (*) in the urine of infected hamsters (n = 3). Each lane contained 5 μg of protein. (B) It was revealed, by serial dilution of urine, that HADH increased in the said specimen during the seventh day post infection. These experiments were repeated three times, and the representative data are shown in this figure.


We confirmed, by immunoblotting, that several leptospiral proteins were shed in the urine of infected hamsters from the early phase of infection (Figure 2B). On the 7-8th day post-infection, the amount of 52 and 65 kDa leptospiral antigens increased. It was suggested that the proportion of 30 kDa proteins decreased because of rich albumin passing into the urine. Furthermore, we performed 2-DE for a detailed examination of protein components. Patterns of urinary proteins were different between pre-infection and after the seventh day of infection. As mentioned earlier, the infected hamster urine consisted mostly of albumin, consequently we determined proteins that had increased expression. In 2-DE-immunoblotting, 60 kDa proteins were detected by anti-L. interrogans pAb (Figure 3D). However, though proteins with 52 and 30 kDa molecular weights were detected in SDS-PAGE-immunoblotting (Figure 2B), they were not found by 2-DE-immunoblotting (Figure 3D). This may be because the two proteins were diluted in 2-DE gel during pI separation or had specific pI outside 4–7. From the amino acid sequence, molecular weight of HADH is 52 kDa and this supports the probability that the 52 kDa band in immunoblotting of urine (Figure 2B), recombinant HADH study (Figure 4), and dilution experiments of urine (Figure 5) is leptospiral HADH. However in 2-DE-immunoblotting analysis, anti-L. interrogans pAb detected around 60 kDa protein which is revealed as leptospiral HADH by LC/MS/MS. Molecular weight shift like this (from 52 to 60 kDa) is sometimes observed in these kinds of experiments, and HADH was included in 60 kDa proteins in the 2-DE- immunoblotting (Figure 3D).

The most significant finding in our study was the detection in infected hamster urine of leptospiral protein LIC13300, which is 3-hydroxyacyl-CoA dehydrogenase (HADH) and is one of the intracellular enzyme proteins. This protein is classified as an oxidoreductase in fatty acid metabolic processes. It specifically catalyzes the third step of beta oxidation. Long-chain fatty acids are utilized by Leptospira as the sole carbon source and are metabolized by beta-oxidation. Therefore, a large amount of HADH may be produced intracellularly and released to get carbons and energy by oxidizing free fatty acid.

We produced rabbit antiserum against recombinant leptospiral HADH to detect the protein in infected hamster urine. The advantage of using anti-HADH pAb compared to the anti-pathogenic leptospires pAb is that the former is more specific than the latter. Using this antiserum, the protein (52 kDa) was successfully detected in urine after infection (Figure 5A), and an increase in band thickness at 7–8 days post infection was confirmed by serial dilution (Figure 5B). It seems that the appearance of 65 kDa protein in immunoblotting (Figure 5A) was due to non-specific reactions because normal hamster urine had the 65 kDa protein (Figure 5A) and normal rabbit serum also reacted with such protein (data not shown). During 0–6 days after infection, urine still appeared normal and leptospires were not shed in urine. Further study is needed to identify these proteins.

Hamsters and humans also have enzymes similar to leptospiral HADH. The amino acid sequences of this protein are conserved among Leptospira spp., however, the amino acid homology between hamster or human and L. interrogans serovar Copenhageni were only 25.08% or 32.44%, respectively. It is, therefore, expected that the antisera against leptospiral HADH cannot recognize the protein of hamsters.

Several studies previously reported that the abundant proteins or LPS on the surface of outer membrane were suitable as targets for vaccine and diagnosis of leptospirosis such as outer membrane proteins [38, 39], LIC11207 [40], OmpL1 [41, 42], MPL17 and MPL21 [43], HbpA [44], LigA [45], LP29 and LP49 [46], LipL32 [4750], LipL21 [50, 51], LipL41 [42], flagellin protein [52]. Moreover, it was also reported that different proteins were expressed in leptospires shed in chronically infected rats compared to leptospires cultured in vitro[53], and that the leptospires in rat urine affected urinary protein composition [54]. However, we were not able to identify any of the previously reported leptospiral proteins in the urine either by immunoblotting with anti-L. interrogans pAb or MS/MS analysis. The polyclonal antibodies were produced in rabbits, and we confirmed that proteins were recognized by this antibody using immunoblotting and MS/MS analyses. The antibody could recognize some membrane proteins such as LipL32 and LipL41 when bacterial cells were used for immunoblotting (unpublished data). However, leptospiral membrane lipoproteins were not detected in the urine, probably due to their low concentration. These results suggest that not only membrane proteins but also intracellular proteins, such as HADH, can be used as candidates for leptospirosis diagnosis.

We investigated the changes in the attributes of hamster urine prior to infection and a day just before death in a hamster model, and found that the conditions drastically changed one day prior to death. The pH of hamster urine is usually about 8, and it was found to have become acidic before death (Figure 1B). Urinary test results suggest that this acidification was caused by renal failure, like nephritis. Hamster urine is usually cloudy due to a high concentration of calcium carbonate [55]. But, it became clear on the day prior to death due to leptospirosis. Calcium carbonate is deposited in alkali conditions, and dissolved in acidic conditions. Leptospira- infected hamster urine was about pH 6, and the urine remained clear even in alkaline condition induced by adding sodium hydroxide. It means that the amount of calcium carbonate excreted in urine decreased just before the hamsters succumbed to infection. After the seventh day of infection, viable leptospires could be recovered from the urine. Thus, it is suggested that leptospires are not shed from the kidneys until just before death.

Most of the urinary proteins detected in this study were associated with host renal failure such as acute renal transplant rejection [29, 30], glomerular disease [31, 32, 36], diabetes mellitus type 2 [33, 35], chronic kidney disease [34], pancreatitis [31], and endemic nephropathy [37]. The proteins identified in our study, except for leptospiral HADH, are biomarkers known to be involved in renal failure, but are not specific for Leptospira infection. Albumin was the main protein detected in infected hamster urine during the end stage of infection (Figure 2). This is one of the plasma proteins and its primary function is to maintain the colloidal osmotic pressure in both the vascular and extra-vascular spaces. The urine-excreted proteins can serve as markers for glomerular disease [31, 32] and diabetes [33].


HADH was detected in urine before the onset of illness in our hamster model of leptospirosis. This is the first study reporting that leptospiral HADH is released in the urine during the infection. Therefore, this protein could be applicable in early diagnostic assays for human leptospirosis.



Leptospira interrogans serovar Manilae strain K64 that was isolated from the kidneys of a rat in the Philippines [56] was used in this study, and cultured in modified Korthof’s medium supplemented with 10% rabbit serum at 30°C. Prior to experiments, strain K64 was passaged through hamsters to maintain its virulence. Strain K64 passaged less than ten times in vitro was used for experiments. LD50 of strain K64 was determined by infecting hamsters with serially diluted leptospiral suspension [56, 57]. As a result, the LD50 of K64 strain was 100.


Male golden Syrian hamsters (Japan SLC, Inc., Shizuoka, Japan), 4 weeks of age, were injected subcutaneously with 103 low-passaged (less than 10× in vitro) leptospires at a final volume of 1 ml Korthof’s medium. As negative controls, animals were injected with Korthof’s medium only. The urine of infected animals was collected by housing them in metabolic chambers for 6 hours daily until they were moribund. Hamster kidneys, livers, spleens, lungs and brains were collected aseptically and squeezed into modified Korthof’s medium containing 5-FU using 5 ml syringe, and incubated at 30°C [56]. Five hundred microliters of culture supernatant was sub-cultured into fresh medium without 5-FU the next day and was kept at 30°C and examined for growth of leptospires daily for one month. Moribund hamsters and those that survived infection after 9 days were sacrificed through inhalation with sevoflurane (Maruishi Pharmaceutical, Japan).

All animal experiments were reviewed and approved by the Ethics Committee on Animal Experiment at the Faculty of Medical Sciences, Kyushu University. The experiments were carried out following the Regulations for Animal Experiments of Kyushu University and The Law (No. 105) and Notification (No. 6) of the Government of Japan.


The pH of hamster urine was tested using pH test paper BTB (07010060, Advantec, Tokyo, Japan). Glucose, bilirubin, ketone, specific gravity, blood, protein, urobilinogen, nitrite, and leukocyte were measured with N-MULTISTIX® SG-L (Siemens Healthcare Diagnostics Inc., NY). The turbidity of hamster urine was measured using Wallac ARVO sx 1420 multilabel counter (Perkin Elmer, Waltham, MA, USA) at a wavelength of 600 nm.

Pre-treatment of urine for gel electrophoresis

Due to the small amount of urine collected, urine from three infected hamsters was pooled and used in the experiments. For proteomic analysis, urine samples were first centrifuged at 1500 × g for 10 min at 4°C to remove debris. The supernatants were concentrated and desalted to remove interfering substances by centrifugation at 7500 × g for 30 min at 4°C using a centrifugal filter device (Amicon Ultra 4 molecular mass cutoff, 10-kDa; Merck Millipore, Billerica, MA, USA) as previously described [58]. The desalted concentrates were stored at −20°C until further use. Protein concentration in urine was determined using 2-D Quant Kit (GE Healthcare UK Ltd, Little Chalfont, UK) and processed for gel electrophoresis.

Sodium dodecyl sulfide–polyacrylamide gel electrophoresis (SDS-PAGE)

For SDS-PAGE, the concentrated and desalted urine samples were dissolved in Laemmli sample buffer (Bio-Rad Laboratories, BioRad, Hercules, CA, USA) with 5% beta-mercaptoethanol and incubated at 94°C for 5 min. SDS-PAGE was performed with 10% acrylamide gels. Electrophoresis was performed using a Mini-PROTEAN tetra cell (Bio-Rad Laboratories, BioRad, Hercules, CA, USA) for 120 min at 20 mA in Tris-glycine running buffer (25 mM Tris, 192 mM glycine, 0.1% sodium dodecyl sulfate). Separated proteins were stained using Silver Stain MS Kit (WAKO, Osaka, Japan).

Two dimensional electrophoresis (2-DE)

2-DE of the urine samples was analyzed using the Multiphor II Electrophoresis system (GE Healthcare UK Ltd, Little Chalfont, UK) according to the manufacturer’s instructions with some modifications. Briefly, the desalted urine sample was dissolved and recovered with 400 μl of 8 M urea, 4% CHAPS and 50 mM Tris/HCl (pH 8.0). Ten mM DTT and 1% Pharmalyte, broad range pH 3–10 (GE Healthcare UK Ltd, Little Chalfont, UK) including range pH 4–7 were added as rehydration buffer prior to loading for the first dimension. Samples were directly added into the rehydration buffer and the 11 cm immobilized gradient strip (pH 4–7) was allowed to swell overnight at room temperature. The isoelectric focusing (IEF) conditions were as follows: (i) 1 min at a 300 V gradient, (ii) 1.5 h at a 3500 V gradient, (iii) 5 h at 3500 V, with a 50 μA per strip maximum at 15°C. The completed first-dimensional strip was subjected to 2-D SDS-PAGE with 12.5% acrylamide gel. Separated proteins were stained by silver staining as mentioned above.

Cloning and expression of recombinant HADH

A 1311-bp LIC13300 DNA fragment was amplified using oligomers LIC13300-F 5′-GGAATTCCATATGAGAGAAATCAAAACAGTAACAG-3′ and LIC13300-R 5′-CCGCTCGAGTCCTTTGAAAAGTGAACGAGC-3′ designed based on L. interrogans serovar Copenhageni genome sequences (GenBank accession YP_003205). PCR was performed with KOD plus ver. 2 PCR kit (Toyobo, Osaka, Japan) from strain K64. Cycling conditions were: 95°C, 5 min, followed by 40 cycles at 95°C, 1 min, 50°C, 1 min, 68°C, 2 min, and a final extension cycle of 5 min, 68°C. PCR product was digested with Nde I and Xho I (Roche, Basel, Schweiz), ligated to Nde I- and Xho I- digested expression vector, pET-28a (+) (Novagen, San Diego, CA). The ligated plasmid was amplified in E. coli DH5α and purified using Midi PlusTM Ultrapure Plasmid Extraction System (Viogene, Taipei, Taiwan). After confirming the presence of correct inserts by sequence analysis, the plasmid was transformed in E. coli (DE3). Cultures were grown to OD600 = 0.5 and protein expression was induced with 1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG), and incubated at 25°C overnight. His-tagged LIC13300 recombinant protein (rHADH) was purified under native conditions with TALON® Metal Affinity Resin (Clontech) as previously described [59].

Antiserum against rHADH

One female Japanese white rabbit (Biotek. Co.,Ltd., Japan) weighing 1.5 kg was immunized subcutaneously with 30 μg of the recombinant protein. The rHADH was mixed with an equal volume of complete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO) to make an emulsion. Four subsequent booster injections were given at two-week intervals in the same way, by using incomplete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO). One week after the final immunization, the blood of rabbit was collected through cardiac puncture and the serum was analyzed by immunoblotting.


Proteins separated by SDS-PAGE were transferred to an Immobilon-P transfer membrane (Merck Millipore, Billerica, MA, USA) and blocked with 1% (wt/vol) nonfat dry milk (WAKO, Osaka, Japan) in TBS-0.05% Tween 20 (TBS-T). The membranes were incubated overnight at 4°C with polyclonal antibody produced against live whole cells of L. interrogans serovar Manilae (anti-L. interrogans pAb) (1:1000 dilution) [57] or anti-HADH rabbit antiserum polyclonal antibody (1:5000), followed by incubation for 2 h at room temperature with horseradish peroxidase (HRP)-donkey anti-rabbit IgG conjugate (1:5000 dilution; GE Healthcare UK Ltd, Little Chalfont, UK), or with anti-His (C-term) mouse mAb (1:5000 dilution; Life technologies, Carlsbad, CA, USA), followed by incubation for 2 h at room temperature with horseradish peroxidase (HRP)-sheep anti-mouse IgG conjugate (1:10000 dilution; GE Healthcare UK Ltd, Little Chalfont, UK). The bands were detected with EzWest Lumi plus (ATTO, Tokyo, Japan) and ImageQuant LAS 4000mini (GE Healthcare UK Ltd, Little Chalfont, UK).

Liquid chromatography (LC)/mass spectrometry (MS) analysis

Protein spots in gels were compared and analyzed by visual inspection. The gel spots were stored in 1% acetic acid and were subjected to LC/MS/MS analysis. Identification of proteins was carried out using Mascot server (Matrix Science) with datasets of rodent and Leptospira proteomes. A protein score of >40 was used to select proteins with significant matching. The difference between the theoretical and experimental mass and pI was also used to determine significant matching.



3-hydroxyacyl-CoA dehydrogenase


Coomassie brilliant blue


Enzyme-linked immunosorbent assay


Horseradish peroxidase


Isoelectric focusing




Japan International Cooperation Agency


Japan Science and Technology Agency


Liquid chromatography


Mass spectrometry


Microscopic agglutination test

anti-L. interrogans pAb:

Polyclonal antibody produced against live whole cells of L. interrogans serovar Manilae


Polymerase chain reaction


Science and Technology Research Partnership for Sustainable Development


Sodium dodecyl sulfide–polyacrylamide gel electrophoresis


TBS-0.05% Tween 20


Two dimensional electrophoresis.


  1. 1.

    Levett PN: Leptospirosis. Clin Microbiol Rev. 2001, 14 (2): 296-326. 10.1128/CMR.14.2.296-326.2001.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  2. 2.

    Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, Peru-United States Leptospirosis Consortium: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3 (12): 757-771. 10.1016/S1473-3099(03)00830-2.

    Article  PubMed  Google Scholar 

  3. 3.

    Picardeau M: Diagnosis and epidemiology of leptospirosis. Med Mal Infect. 2013, 43 (1): 1-9. 10.1016/j.medmal.2012.11.005.

    Article  CAS  PubMed  Google Scholar 

  4. 4.

    Adler B, de la Pena MA: Leptospira and leptospirosis. Vet Microbiol. 2010, 140 (3–4): 287-296.

    Article  CAS  PubMed  Google Scholar 

  5. 5.

    Toyokawa T, Ohnishi M, Koizumi N: Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011, 9 (1): 111-121. 10.1586/eri.10.151.

    Article  PubMed  Google Scholar 

  6. 6.

    Vijayachari P, Sugunan AP, Shriram AN: Leptospirosis: an emerging global public health problem. J Biosci. 2008, 33 (4): 557-569. 10.1007/s12038-008-0074-z.

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    Camargo ED, da Silva MV, Batista L, Vaz AJ, Sakata EE: An evaluation of the ELISA-IgM test in the early diagnosis of human leptospirosis. Rev Inst Med Trop Sao Paulo. 1992, 34 (4): 355-357.

    Article  CAS  PubMed  Google Scholar 

  8. 8.

    Fonseca Cde A, Teixeira MM, Romero EC, Tengan FM, Silva MV, Shikanai-Yasuda MA: Leptospira DNA detection for the diagnosis of human leptospirosis. J Infect. 2006, 52 (1): 15-22. 10.1016/j.jinf.2005.02.022.

    Article  PubMed  Google Scholar 

  9. 9.

    Balassiano IT, Vital-Brazil JM, Pereira MM: Leptospirosis diagnosis by immunocapture polymerase chain reaction: a new tool for early diagnosis and epidemiologic surveillance. Diagn Microbiol Infect Dis. 2012, 74 (1): 11-15. 10.1016/j.diagmicrobio.2012.05.028.

    Article  CAS  PubMed  Google Scholar 

  10. 10.

    Koizumi N, Watanabe H, Umezawa K, Iiduka T, Inokuchi S: A case of leptospirosis diagnosed early by flaB-PCR. Kansenshogaku Zasshi. 2003, 77 (8): 627-630.

    Article  PubMed  Google Scholar 

  11. 11.

    Brown PD, Gravekamp C, Carrington DG, van de Kemp H, Hartskeerl RA, Edwards CN, Everard CO, Terpstra WJ, Levett PN: Evaluation of the polymerase chain reaction for early diagnosis of leptospirosis. J Med Microbiol. 1995, 43 (2): 110-114. 10.1099/00222615-43-2-110.

    Article  CAS  PubMed  Google Scholar 

  12. 12.

    Goris MG, Leeflang MM, Loden M, Wagenaar JF, Klatser PR, Hartskeerl RA, Boer KR: Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis. PLoS Negl Trop Dis. 2013, 7 (7): e2290-10.1371/journal.pntd.0002290.

    PubMed Central  Article  PubMed  Google Scholar 

  13. 13.

    Ooteman MC, Vago AR, Koury MC: Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods. 2006, 65 (2): 247-257. 10.1016/j.mimet.2005.07.015.

    Article  CAS  PubMed  Google Scholar 

  14. 14.

    McBride AJ, Santos BL, Queiroz A, Santos AC, Hartskeerl RA, Reis MG, Ko AI: Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis. Clin Vaccine Immunol. 2007, 14 (9): 1245-1248. 10.1128/CVI.00217-07.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  15. 15.

    Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41 (2): 803-809. 10.1128/JCM.41.2.803-809.2003.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  16. 16.

    Eapen CK, Sugathan S, Kuriakose M, Abdoel T, Smits HL: Evaluation of the clinical utility of a rapid blood test for human leptospirosis. Diagn Microbiol Infect Dis. 2002, 42 (4): 221-225. 10.1016/S0732-8893(01)00361-3.

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Signorini ML, Lottersberger J, Tarabla HD, Vanasco NB: Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect. 2013, 141 (1): 22-32. 10.1017/S0950268812001951.

    Article  CAS  PubMed  Google Scholar 

  18. 18.

    Musso D, La Scola B: Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol Infect. 2013, 46 (4): 245-252. 10.1016/j.jmii.2013.03.001.

    Article  CAS  PubMed  Google Scholar 

  19. 19.

    Widiyanti D, Koizumi N, Fukui T, Muslich LT, Segawa T, Villanueva SY, Saito M, Masuzawa T, Gloriani NG, Yoshida S: Development of immunochromatography-based methods for detection of leptospiral lipopolysaccharide antigen in urine. Clin Vaccine Immunol. 2013, 20 (5): 683-690. 10.1128/CVI.00756-12.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  20. 20.

    Saengjaruk P, Chaicumpa W, Watt G, Bunyaraksyotin G, Wuthiekanun V, Tapchaisri P, Sittinont C, Panaphut T, Tomanakan K, Sakolvaree Y, Chongsa-Nguan M, Mahakunkijcharoen Y, Kalambaheti T, Naigowit P, Wambangco MA, Kurazono H, Hayashi H: Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J Clin Microbiol. 2002, 40 (2): 480-489. 10.1128/JCM.40.3.480-489.2002.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  21. 21.

    Ruiz VM, Vega LE, Velazquez RM: Use of polymerase chain reaction for the identification of Leptospira sp. in urine of carriers. Rev Cubana Med Trop. 2005, 57 (1): 47-48.

    PubMed  Google Scholar 

  22. 22.

    Koizumi N, Nakajima C, Harunari T, Tanikawa T, Tokiwa T, Uchimura E, Furuya T, Mingala CN, Villanueva MA, Ohnishi M, Suzuki Y: A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine. J Clin Microbiol. 2012, 50 (6): 2072-2074. 10.1128/JCM.00481-12.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  23. 23.

    Bomfim MR, Barbosa-Stancioli EF, Koury MC: Detection of pathogenic leptospires in urine from naturally infected cattle by nested PCR. Vet J. 2008, 178 (2): 251-256. 10.1016/j.tvjl.2007.07.029.

    Article  CAS  PubMed  Google Scholar 

  24. 24.

    Suwimonteerabutr J, Chaicumpa W, Saengjaruk P, Tapchaisri P, Chongsa-nguan M, Kalambaheti T, Ramasoota P, Sakolvaree Y, Virakul P: Evaluation of a monoclonal antibody-based dot-blot ELISA for detection of Leptospira spp in bovine urine samples. Am J Vet Res. 2005, 66 (5): 762-766. 10.2460/ajvr.2005.66.762.

    Article  CAS  PubMed  Google Scholar 

  25. 25.

    Bal AE, Gravekamp C, Hartskeerl RA, De Meza-Brewster J, Korver H, Terpstra WJ: Detection of leptospires in urine by PCR for early diagnosis of leptospirosis. J Clin Microbiol. 1994, 32 (8): 1894-1898.

    PubMed Central  CAS  PubMed  Google Scholar 

  26. 26.

    Bolin CA, Zuerner RL, Trueba G: Comparison of three techniques to detect Leptospira interrogans serovar Hardjo type hardjo-bovis in bovine urine. Am J Vet Res. 1989, 50 (7): 1001-1003.

    CAS  PubMed  Google Scholar 

  27. 27.

    Rai AJ: The urinary proteome. 2010, 641: 361-,

    Google Scholar 

  28. 28.

    Haake DA: Hamster model of leptospirosis. Curr Protoc Microbiol. 2006, Chapter 12 (Unit 12E): 2-

    PubMed  Google Scholar 

  29. 29.

    Sigdel TK, Kaushal A, Gritsenko M, Norbeck AD, Qian WJ, Xiao W, Camp DG, Smith RD, Sarwal MM: Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl. 2010, 4 (1): 32-47. 10.1002/prca.200900124.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  30. 30.

    Loftheim H, Midtvedt K, Hartmann A, Reisaeter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A: Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res. 2012, 1 (1): 9-10.1186/2047-1440-1-9.,

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  31. 31.

    Burtis CA, Ashwood ER, Tietz NW: Tietz Textbook of Clinical Chemistry. 1999, Philadelphia: W.B. Saunders, 3

    Google Scholar 

  32. 32.

    Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM: Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007, 18 (3): 913-922. 10.1681/ASN.2006070767.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  33. 33.

    Riaz S, Skinner V, Srai SK: Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2. J Pharm Biomed Anal. 2011, 54 (4): 817-825. 10.1016/j.jpba.2010.11.008.

    Article  CAS  PubMed  Google Scholar 

  34. 34.

    Burns KD, Hiremath S: Urinary angiotensinogen as a biomarker of chronic kidney disease: ready for prime time?. Nephrol Dial Transplant. 2012, 27 (8): 3010-3013. 10.1093/ndt/gfs166.

    Article  CAS  PubMed  Google Scholar 

  35. 35.

    Penders J, Delanghe JR: Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta. 2004, 346 (2): 107-118. 10.1016/j.cccn.2004.03.037.

    Article  CAS  PubMed  Google Scholar 

  36. 36.

    Short CD, Durrington PN, Mallick NP, Hunt LP, Tetlow L, Ishola M: Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int. 1986, 29 (6): 1224-1228. 10.1038/ki.1986.131.

    Article  CAS  PubMed  Google Scholar 

  37. 37.

    Pesic I, Stefanovic V, Muller GA, Muller CA, Cukuranovic R, Jahn O, Bojanic V, Koziolek M, Dihazi H: Identification and validation of six proteins as marker for endemic nephropathy. J Proteomics. 2011, 74 (10): 1994-2007. 10.1016/j.jprot.2011.05.020.

    Article  CAS  PubMed  Google Scholar 

  38. 38.

    Lessa-Aquino C, Borges Rodrigues C, Pablo J, Sasaki R, Jasinskas A, Liang L, Wunder EA, Ribeiro GS, Vigil A, Galler R, Molina D, Liang X, Reis MG, Ko AI, Medeiros MA, Felgner PL: Identification of seroreactive proteins of Leptospira interrogans serovar Copenhageni using a high-density protein microarray approach. PLoS Negl Trop Dis. 2013, 7 (10): e2499-10.1371/journal.pntd.0002499.

    PubMed Central  Article  PubMed  Google Scholar 

  39. 39.

    Raja V, Natarajaseenivasan K: Pathogenic, diagnostic and vaccine potential of leptospiral outer membrane proteins (OMPs). Crit Rev Microbiol. 2013,,

    Google Scholar 

  40. 40.

    Pretre G, Lapponi MJ, Atzingen MV, Schattner M, Nascimento AL, Gomez RM: Characterization of LIC11207, a novel leptospiral protein that is recognized by human convalescent sera and prevents apoptosis of polymorphonuclear leukocytes. Microb Pathog. 2013, 56: 21-28.

    Article  CAS  PubMed  Google Scholar 

  41. 41.

    Subathra M, Senthilkumar TM, Ramadass P: Recombinant OmpL1 protein as a diagnostic antigen for the detection of canine leptospirosis. Appl Biochem Biotechnol. 2013, 169 (2): 431-437. 10.1007/s12010-012-9973-4.

    Article  CAS  PubMed  Google Scholar 

  42. 42.

    Natarajaseenivasan K, Vijayachari P, Sharma S, Sugunan AP, Selvin J, Sehgal SC: Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar Autumnalis. Ann Trop Med Parasitol. 2008, 102 (8): 699-708. 10.1179/136485908X355229.

    Article  CAS  PubMed  Google Scholar 

  43. 43.

    Oliveira TR, Longhi MT, de Morais ZM, Romero EC, Blanco RM, Kirchgatter K, Vasconcellos SA, Nascimento AL: Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin Vaccine Immunol. 2008, 15 (11): 1715-1722. 10.1128/CVI.00214-08.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  44. 44.

    Sridhar V, Manjulata Devi S, Ahmed N, Sritharan M: Diagnostic potential of an iron-regulated hemin-binding protein HbpA that is widely conserved in Leptospira interrogans. Infect Genet Evol. 2008, 8 (6): 772-776. 10.1016/j.meegid.2008.07.004.

    Article  CAS  PubMed  Google Scholar 

  45. 45.

    Srimanote P, Wongdeethai N, Jieanampunkul P, Samonkiert S, Leepiyasakulchai C, Kalambaheti T, Prachayasittikul V: Recombinant LigA for leptospirosis diagnosis and LigA among the Leptospira spp. clinical isolates. J Microbiol Methods. 2008, 72 (1): 73-81. 10.1016/j.mimet.2007.10.012.

    Article  CAS  PubMed  Google Scholar 

  46. 46.

    Neves FO, Abreu PA, Vasconcellos SA, de Morais ZM, Romero EC, Nascimento AL: Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch Microbiol. 2007, 188 (5): 523-532. 10.1007/s00203-007-0273-2.

    Article  CAS  PubMed  Google Scholar 

  47. 47.

    Coutinho ML, Vasconcellos FA, Fernandes CP, Seyffert N, Seixas FK, Ko AI, Dellagostin OA, Aleixo JA: Evaluation of the anti-LipL32 monoclonal antibodies potential for use in leptospirosis immunodiagnostic tests. J Immunoassay Immunochem. 2007, 28 (3): 279-288. 10.1080/15321810701454870.

    Article  CAS  PubMed  Google Scholar 

  48. 48.

    Humphryes PC, Weeks ME, Gielbert A, Thomson G, Coldham NG: Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency. Clin Vaccine Immunol. 2012, 19 (4): 587-593. 10.1128/CVI.05622-11.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  49. 49.

    Kucerova P, Cermakova Z, Pliskova L, Pavlis O, Kubickova P, Kleprlikova H, Valenta Z: Our experience using real-time PCR for the detection of the gene that encodes the superficial lipoprotein LipL32 of the pathogenic leptospires to confirm the acute form of human leptospirosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013, 157 (4): 387-391.

    CAS  PubMed  Google Scholar 

  50. 50.

    Cheemaa PS, Srivastava SK, Amutha R, Singh S, Singh H, Sandey M: Detection of pathogenic leptospires in animals by PCR based on lipL21 and lipL32 genes. Indian J Exp Biol. 2007, 45 (6): 568-573.

    CAS  PubMed  Google Scholar 

  51. 51.

    Joseph S, Thomas N, Thangapandian E, Singh VP, Verma R, Srivastava SK: Evaluation and comparison of native and recombinant LipL21 protein-based ELISAs for diagnosis of bovine leptospirosis. J Vet Sci. 2012, 13 (1): 99-101. 10.4142/jvs.2012.13.1.99.

    PubMed Central  Article  PubMed  Google Scholar 

  52. 52.

    Bughio NI, Lin M, Surujballi OP: Use of recombinant flagellin protein as a tracer antigen in a fluorescence polarization assay for diagnosis of leptospirosis. Clin Diagn Lab Immunol. 1999, 6 (4): 599-605.

    PubMed Central  CAS  PubMed  Google Scholar 

  53. 53.

    Monahan AM, Callanan JJ, Nally JE: Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun. 2008, 76 (11): 4952-4958. 10.1128/IAI.00511-08.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  54. 54.

    Nally JE, Monahan AM, Miller IS, Bonilla-Santiago R, Souda P, Whitelegge JP: Comparative proteomic analysis of differentially expressed proteins in the urine of reservoir hosts of leptospirosis. PLoS One. 2011, 6 (10): e26046-10.1371/journal.pone.0026046.

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  55. 55.

    Syrian Hamsters: biology: urine.,

  56. 56.

    Villanueva SY, Ezoe H, Baterna RA, Yanagihara Y, Muto M, Koizumi N, Fukui T, Okamoto Y, Masuzawa T, Cavinta LL, Gloriani NG, Yoshida S: Serologic and molecular studies of Leptospira and leptospirosis among rats in the Philippines. Am J Trop Med Hyg. 2010, 82 (5): 889-898. 10.4269/ajtmh.2010.09-0711.

    PubMed Central  Article  PubMed  Google Scholar 

  57. 57.

    Villanueva SY, Saito M, Tsutsumi Y, Segawa T, Baterna RA, Chakraborty A, Asoh T, Miyahara S, Yanagihara Y, Cavinta LL, Gloriani NG, Yoshida SI: High virulence in hamsters of four dominantly prevailing Leptospira serovars isolated from rats in the Philippines. Microbiology. 2014, 160 (Pt 2): 418-428.

    Article  CAS  PubMed  Google Scholar 

  58. 58.

    Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H: Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics. 2007, 6 (4): 738-744. 10.1074/mcp.M600336-MCP200.

    Article  CAS  PubMed  Google Scholar 

  59. 59.

    Yoshimura S, Haas AK, Barr FA: Analysis of Rab GTPase and GTPase-activating protein function at primary cilia. Methods Enzymol. 2008, 439: 353-364.

    Article  CAS  PubMed  Google Scholar 

Download references


This study was supported by a grant of the Science and Technology Research Partnership for Sustainable Development (SATREPS) program from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA). We thank Dr. H. Sumimoto and colleagues of the Research Support Center, Graduate School of Medical Sciences, Kyushu University for their technical support and advice. We also thank Sayaka Akiyoshi, Takayoshi Yamaguchi, Hideko Kameyama, and Naomi Hidaka for their technical cooperation.

Author information



Corresponding author

Correspondence to Takaya Segawa.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TS designed portions of the study, carried out all the experiments, and drafted the manuscript. KHN designed portions of the study, participated in the immunoassay, and revised the manuscript. SYAMV participated in the immunoassay and revised the manuscript. MS designed portions of the study and revised the manuscript. KN participated in the proteomic analysis and revised the manuscript. NGG participated in the design of the study. SY conceived and designed portions of the study, and revised the manuscript. All authors read and approved the final manuscript.

Electronic supplementary material

Authors’ original submitted files for images

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Segawa, T., Nomura, K.H., Villanueva, S.Y.A.M. et al. Identification of leptospiral 3-hydroxyacyl-CoA dehydrogenase released in the urine of infected hamsters. BMC Microbiol 14, 132 (2014).

Download citation


  • Leptospirosis
  • 3-hydroxyacyl-CoA dehydrogenase
  • Urine
  • Hamster
  • Diagnosis